{"id":"https://genegraph.clinicalgenome.org/r/acb26abf-db7d-4b29-9648-ce4cdd4ca3d6v1.0","type":"EvidenceStrengthAssertion","dc:description":"CHN1 was first reported in relation to autosomal dominant Duane retraction syndrome 2 in 2008 (Miyake et al., PMID:18653847). Duane retraction syndrome 2 is a congenital disorder characterized by restricted horizontal eye movement with globe retraction and palpebral fissure narrowing on attempted adduction. 12 missense variants that have been reported in 13 probands in 5 publications (PMIDs: 18653847, 21555619, 21715346, 29031989, 33004823) are included in this curation. The mechanism of pathogenicity has been reported to be gain of function. This gene-disease relationship is also supported by an animal model (PMID: 28346224). In summary, there is moderate evidence supporting the relationship between CHN1 and Duane retraction syndrome 2. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Brain Malformations GCEP on the meeting date December July 26, 2022 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/acb26abf-db7d-4b29-9648-ce4cdd4ca3d6","GCISnapshot":"https://genegraph.clinicalgenome.org/r/c19544e0-2fb1-4d8a-b1ad-f493068f76bb","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/c19544e0-2fb1-4d8a-b1ad-f493068f76bb_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10020","date":"2024-03-20T18:44:39.945Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/c19544e0-2fb1-4d8a-b1ad-f493068f76bb_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10020","date":"2022-07-26T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c19544e0-2fb1-4d8a-b1ad-f493068f76bb_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e95f3c6-de89-41c1-b8c1-ab5a119a312f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e95f3c6-de89-41c1-b8c1-ab5a119a312f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"To determine whether DURS2 mutations alter the RacGAP activity of α2-chimaerin, they made full-length wild-type and mutant α2-chimaerin constructs that expressed equally stable proteins in HEK293T cells and primary neurons. Consistent with α2-chimaerin function, wild-type overexpression resulted in a reduction in Rac-GTP levels from baseline in HEK293T cells. As predicted, overexpression of mutant α2-chimaerin protein resulted in a significant further reduction in Rac-GTP levels when compared to wild-type protein.","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/3e95f3c6-de89-41c1-b8c1-ab5a119a312f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18653847","allele":{"id":"https://genegraph.clinicalgenome.org/r/7aa1acda-95aa-4463-8250-458e41061de2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001822.7(CHN1):c.682G>A (p.Gly228Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258038"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d11eae67-ad3d-4922-acea-d6d94adf7fc3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d11eae67-ad3d-4922-acea-d6d94adf7fc3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"To determine whether DURS2 mutations alter the RacGAP activity of α2-chimaerin, they made full-length wild-type and mutant α2-chimaerin constructs that expressed equally stable proteins in HEK293T cells and primary neurons. Consistent with α2-chimaerin function, wild-type overexpression resulted in a reduction in Rac-GTP levels from baseline in HEK293T cells. As predicted, overexpression of mutant α2-chimaerin protein resulted in a significant further reduction in Rac-GTP levels when compared to wild-type protein.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d11eae67-ad3d-4922-acea-d6d94adf7fc3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18653847","allele":{"id":"https://genegraph.clinicalgenome.org/r/1a2b1aea-ca04-497f-900d-74663a829a67","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001822.7(CHN1):c.668C>T (p.Ala223Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258037"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/17e3f21d-a6e3-4591-a655-af7c4f910213","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/17e3f21d-a6e3-4591-a655-af7c4f910213_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"To determine whether DURS2 mutations alter the RacGAP activity of α2-chimaerin, they made full-length wild-type and mutant α2-chimaerin constructs that expressed equally stable proteins in HEK293T cells and primary neurons. Consistent with α2-chimaerin function, wild-type overexpression resulted in a reduction in Rac-GTP levels from baseline in HEK293T cells. As predicted, overexpression of mutant α2-chimaerin protein resulted in a significant further reduction in Rac-GTP levels when compared to wild-type protein.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/17e3f21d-a6e3-4591-a655-af7c4f910213_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18653847","allele":{"id":"https://genegraph.clinicalgenome.org/r/566d3d8f-02b8-4567-9a31-26ffed9b134b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001822.7(CHN1):c.60A>T (p.Leu20Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258034"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6c22d978-bd22-490a-b339-930ec68de93f","type":"EvidenceLine","dc:description":"We upgrade E313K to 0.5 since it is a recurrent variant. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6c22d978-bd22-490a-b339-930ec68de93f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":" ","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/6c22d978-bd22-490a-b339-930ec68de93f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18653847","allele":{"id":"https://genegraph.clinicalgenome.org/r/d877e56f-e563-440a-8161-9a0785ba6067","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001822.7(CHN1):c.937G>A (p.Glu313Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258040"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/87f1db5b-18a6-4860-ae48-a0a3aaa87a86","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/87f1db5b-18a6-4860-ae48-a0a3aaa87a86_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33004823","allele":{"id":"https://genegraph.clinicalgenome.org/r/4438c8bd-96db-49e8-bb48-fc8bc946dff2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001822.7(CHN1):c.637T>G (p.Phe213Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA349347946"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/83803ff1-6a88-4143-865a-6c300ccf02c3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/83803ff1-6a88-4143-865a-6c300ccf02c3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":" Rac-GTP levels were measured in HEK293T cells transfected with plasmids encoding for myc-ephexin, V5-empty vector, V5-α2-chimaerin wild-type, or V5-α2-chimaerin mutant. Rac-GTP levels are reduced by overexpression of wild-type α2-chimaerin compared to empty vector, and further reduced in cells expressing mutant.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/83803ff1-6a88-4143-865a-6c300ccf02c3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18653847","allele":{"id":"https://genegraph.clinicalgenome.org/r/07b65bb1-1c7e-4b12-955d-d17ae365b80b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001822.7(CHN1):c.755C>A (p.Pro252Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258039"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/910737b8-9af4-48fe-9f9d-95b6e047fc2b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/910737b8-9af4-48fe-9f9d-95b6e047fc2b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29031989","allele":{"id":"https://genegraph.clinicalgenome.org/r/ecbf0e60-f655-4f8c-be9e-8a9aee2b8750","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001822.7(CHN1):c.671A>G (p.Asn224Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA349347803"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/998c225e-dee5-4983-a1bf-4ce1c3768f98","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/998c225e-dee5-4983-a1bf-4ce1c3768f98_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Using a Rac-GTP activation assay (as described in Miyake et al.), they found that the mutant Y148F lowered Rac-GTP levels more than wild-type.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/998c225e-dee5-4983-a1bf-4ce1c3768f98_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21715346","allele":{"id":"https://genegraph.clinicalgenome.org/r/031a9250-30e9-4441-92b8-f4210ae413e1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001822.7(CHN1):c.443A>T (p.Tyr148Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA349689626"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/609d4613-7d59-4347-bf70-0d717608db04","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/609d4613-7d59-4347-bf70-0d717608db04_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"To determine whether DURS2 mutations alter the RacGAP activity of α2-chimaerin, they made full-length wild-type and mutant α2-chimaerin constructs that expressed equally stable proteins in HEK293T cells and primary neurons. Consistent with α2-chimaerin function, wild-type overexpression resulted in a reduction in Rac-GTP levels from baseline in HEK293T cells. As predicted, overexpression of mutant α2-chimaerin protein resulted in a significant further reduction in Rac-GTP levels when compared to wild-type protein.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/609d4613-7d59-4347-bf70-0d717608db04_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18653847","allele":{"id":"https://genegraph.clinicalgenome.org/r/6228c941-ee4e-4caf-8b48-a64dc0642a37","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001822.7(CHN1):c.378T>G (p.Ile126Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258035"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/19e1357c-468b-4077-be0e-2f59ffb861a9","type":"EvidenceLine","dc:description":"The same amino acid position is implicated in another variant (p.P252Q). ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/19e1357c-468b-4077-be0e-2f59ffb861a9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21555619","allele":{"id":"https://genegraph.clinicalgenome.org/r/e3a39605-78c7-4a27-81d5-855b59a69857","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001822.7(CHN1):c.754C>T (p.Pro252Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA259608"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f1e813c3-b5f0-456e-9947-b092234bbaa6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f1e813c3-b5f0-456e-9947-b092234bbaa6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"To determine whether DURS2 mutations alter the RacGAP activity of α2-chimaerin, they made full-length wild-type and mutant α2-chimaerin constructs that expressed equally stable proteins in HEK293T cells and primary neurons. Consistent with α2-chimaerin function, wild-type overexpression resulted in a reduction in Rac-GTP levels from baseline in HEK293T cells. As predicted, overexpression of mutant α2-chimaerin protein resulted in a significant further reduction in Rac-GTP levels when compared to wild-type protein.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/f1e813c3-b5f0-456e-9947-b092234bbaa6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18653847","allele":{"id":"https://genegraph.clinicalgenome.org/r/6ac41458-86f1-4d6d-9152-06d5a9096c41","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001822.7(CHN1):c.427T>C (p.Tyr143His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258036"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d0b97ddf-9014-48e8-b367-a430da48b425","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d0b97ddf-9014-48e8-b367-a430da48b425_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21555619","allele":{"id":"https://genegraph.clinicalgenome.org/r/bf4f0b81-6671-4dd2-a9ed-7a7c88862a48","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001822.7(CHN1):c.422C>T (p.Pro141Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA259606"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/00b4707a-5d4f-40b5-8f7d-f1891eaf3ee3","type":"EvidenceLine","dc:description":"We upgraded p.E313K because it is a recurrent variant. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00b4707a-5d4f-40b5-8f7d-f1891eaf3ee3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID:18653847","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/00b4707a-5d4f-40b5-8f7d-f1891eaf3ee3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29031989","allele":{"id":"https://genegraph.clinicalgenome.org/r/d877e56f-e563-440a-8161-9a0785ba6067"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c19544e0-2fb1-4d8a-b1ad-f493068f76bb_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0de1c639-9381-4423-a427-de9af323b7a3_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21715346","rdfs:label":"JB","estimatedLodScore":2.71,"family":{"id":"https://genegraph.clinicalgenome.org/r/0de1c639-9381-4423-a427-de9af323b7a3","type":"Family","rdfs:label":"JB","member":{"id":"https://genegraph.clinicalgenome.org/r/679fc158-d278-40cd-9c79-d5d39b7021d0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21715346","rdfs:label":"III-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/031a9250-30e9-4441-92b8-f4210ae413e1"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0000486","obo:HP_0000497","obo:HP_0000634","obo:HP_0000542"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/998c225e-dee5-4983-a1bf-4ce1c3768f98_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"All five clinically affected family members exhibited monocular or binocular supraduction deficits, three in the absence of Duane retraction syndrome.","phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/679fc158-d278-40cd-9c79-d5d39b7021d0"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/849cb926-a570-4ba8-9943-024e8e2dfd0e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21555619","rdfs:label":"ABK","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/849cb926-a570-4ba8-9943-024e8e2dfd0e","type":"Family","rdfs:label":"ABK","member":{"id":"https://genegraph.clinicalgenome.org/r/a1e8f234-fde5-4d2b-bc4b-25d90d46a585","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21555619","rdfs:label":"ABK-P","allele":{"id":"https://genegraph.clinicalgenome.org/r/bf4f0b81-6671-4dd2-a9ed-7a7c88862a48"},"firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0000486","obo:HP_0000497","obo:HP_0000634","obo:HP_0000542"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d0b97ddf-9014-48e8-b367-a430da48b425_variant_evidence_item"}}},"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/a1e8f234-fde5-4d2b-bc4b-25d90d46a585"}},{"id":"https://genegraph.clinicalgenome.org/r/8e8eb795-d2f9-46a5-a03c-f04eab226436_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18653847","rdfs:label":"RF","estimatedLodScore":6.32,"family":{"id":"https://genegraph.clinicalgenome.org/r/8e8eb795-d2f9-46a5-a03c-f04eab226436","type":"Family","rdfs:label":"RF","member":{"id":"https://genegraph.clinicalgenome.org/r/52e1dfa0-fd40-4a4f-9a47-8a92b0f93443","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18653847","rdfs:label":"RF-P","allele":{"id":"https://genegraph.clinicalgenome.org/r/6228c941-ee4e-4caf-8b48-a64dc0642a37"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000542","obo:HP_0000486","obo:HP_0000634","obo:HP_0000497"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/609d4613-7d59-4347-bf70-0d717608db04_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":12,"proband":{"id":"https://genegraph.clinicalgenome.org/r/52e1dfa0-fd40-4a4f-9a47-8a92b0f93443"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/6c9648e3-4dc0-4a85-9aab-e371b820199c_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18653847","rdfs:label":"IJ","estimatedLodScore":6.92,"family":{"id":"https://genegraph.clinicalgenome.org/r/6c9648e3-4dc0-4a85-9aab-e371b820199c","type":"Family","rdfs:label":"IJ","member":{"id":"https://genegraph.clinicalgenome.org/r/09fe9d81-40f4-4487-806c-a872f2f1c2fe","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18653847","rdfs:label":"IJ-P","allele":{"id":"https://genegraph.clinicalgenome.org/r/07b65bb1-1c7e-4b12-955d-d17ae365b80b"},"phenotypes":["obo:HP_0000486","obo:HP_0000497","obo:HP_0000542","obo:HP_0000634"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/83803ff1-6a88-4143-865a-6c300ccf02c3_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Duane syndrome","phenotypePositiveAllelePositive":16,"proband":{"id":"https://genegraph.clinicalgenome.org/r/09fe9d81-40f4-4487-806c-a872f2f1c2fe"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/bd67226a-47fe-4192-870d-da4d913fa1ab_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18653847","rdfs:label":"IS","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/bd67226a-47fe-4192-870d-da4d913fa1ab","type":"Family","rdfs:label":"IS"},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":3,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/f7720a11-528f-43b8-86d4-87fc04ffedec_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33004823","rdfs:label":"F1","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/f7720a11-528f-43b8-86d4-87fc04ffedec","type":"Family","rdfs:label":"F1","member":{"id":"https://genegraph.clinicalgenome.org/r/b4c54d69-0532-41d4-bbb3-99981d0226c0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33004823","rdfs:label":"IV:6","allele":{"id":"https://genegraph.clinicalgenome.org/r/4438c8bd-96db-49e8-bb48-fc8bc946dff2"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"phenotypes":["obo:HP_0000542","obo:HP_0000634","obo:HP_0000497","obo:HP_0000486"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/87f1db5b-18a6-4860-ae48-a0a3aaa87a86_variant_evidence_item"}}},"phenotypePositiveAllelePositive":8,"proband":{"id":"https://genegraph.clinicalgenome.org/r/b4c54d69-0532-41d4-bbb3-99981d0226c0"}},{"id":"https://genegraph.clinicalgenome.org/r/fd30381c-37a4-46e4-bc1c-8a5dbfcd7014_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18653847","rdfs:label":"FY","estimatedLodScore":6.92,"family":{"id":"https://genegraph.clinicalgenome.org/r/fd30381c-37a4-46e4-bc1c-8a5dbfcd7014","type":"Family","rdfs:label":"FY","member":{"id":"https://genegraph.clinicalgenome.org/r/58a85534-e574-43ce-ba21-777e432818b2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18653847","rdfs:label":"FY-P","allele":{"id":"https://genegraph.clinicalgenome.org/r/566d3d8f-02b8-4567-9a31-26ffed9b134b"},"phenotypes":["obo:HP_0000497","obo:HP_0000486","obo:HP_0000542","obo:HP_0000634"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/17e3f21d-a6e3-4591-a655-af7c4f910213_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":5,"proband":{"id":"https://genegraph.clinicalgenome.org/r/58a85534-e574-43ce-ba21-777e432818b2"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/25dda5bc-907d-4856-b157-cfefe108237f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21555619","rdfs:label":"ACL","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/25dda5bc-907d-4856-b157-cfefe108237f","type":"Family","rdfs:label":"ACL","member":{"id":"https://genegraph.clinicalgenome.org/r/461a00fd-7647-4dfb-9a32-9e57d241f403","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21555619","rdfs:label":"ACL-P","allele":{"id":"https://genegraph.clinicalgenome.org/r/e3a39605-78c7-4a27-81d5-855b59a69857"},"firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0000634","obo:HP_0000542","obo:HP_0000497","obo:HP_0000486"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/19e1357c-468b-4077-be0e-2f59ffb861a9_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/461a00fd-7647-4dfb-9a32-9e57d241f403"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/aaa98226-aad2-455d-a904-7d1627f57f9d_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18653847","rdfs:label":"AB","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/aaa98226-aad2-455d-a904-7d1627f57f9d","type":"Family","rdfs:label":"AB"},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":2,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/8d975ec7-f20f-49ae-a5ce-6ad086ce0aec_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18653847","rdfs:label":"JH","estimatedLodScore":3.91,"family":{"id":"https://genegraph.clinicalgenome.org/r/8d975ec7-f20f-49ae-a5ce-6ad086ce0aec","type":"Family","rdfs:label":"JH","member":{"id":"https://genegraph.clinicalgenome.org/r/57e973ed-7afe-4ed0-823a-118dd43b0d44","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18653847","rdfs:label":"JH-P","allele":{"id":"https://genegraph.clinicalgenome.org/r/6ac41458-86f1-4d6d-9152-06d5a9096c41"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000497","obo:HP_0000486","obo:HP_0000634","obo:HP_0000542"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f1e813c3-b5f0-456e-9947-b092234bbaa6_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":6,"proband":{"id":"https://genegraph.clinicalgenome.org/r/57e973ed-7afe-4ed0-823a-118dd43b0d44"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/3123fa81-249f-4378-b41f-91adcd3b67d9_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18653847","rdfs:label":"UA","estimatedLodScore":4.21,"family":{"id":"https://genegraph.clinicalgenome.org/r/3123fa81-249f-4378-b41f-91adcd3b67d9","type":"Family","rdfs:label":"UA","member":{"id":"https://genegraph.clinicalgenome.org/r/6765453f-1845-4368-b35b-a7ab2b0c2b29","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18653847","rdfs:label":"P-UA","allele":{"id":"https://genegraph.clinicalgenome.org/r/1a2b1aea-ca04-497f-900d-74663a829a67"},"firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0000542","obo:HP_0000497","obo:HP_0000634","obo:HP_0000486"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d11eae67-ad3d-4922-acea-d6d94adf7fc3_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":9,"proband":{"id":"https://genegraph.clinicalgenome.org/r/6765453f-1845-4368-b35b-a7ab2b0c2b29"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":6.4},{"id":"https://genegraph.clinicalgenome.org/r/c19544e0-2fb1-4d8a-b1ad-f493068f76bb_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c19544e0-2fb1-4d8a-b1ad-f493068f76bb_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/46395f49-e328-472d-b4b8-90be69a48171","type":"EvidenceLine","dc:description":"Whole embryo imaging of CHN1KI/KI mice revealed stalled abducens nerve growth and selective trochlear and first cervical spine nerve guidance abnormalities. Chn1KI/KI mice recapitulates Duane Syndrome phenotype in mice.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/782f334c-886a-4b69-9fa7-f4c658d443d9","type":"Finding","dc:description":"Similar cranial nerve dysinnervation observed in model animal compared to human","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28346224","rdfs:label":"knockin α2-chimaerin mouse (Chn1KI/KI) that models DRS","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3}],"evidenceStrength":"Moderate","sequence":7917,"specifiedBy":"GeneValidityCriteria10","strengthScore":9.4,"subject":{"id":"https://genegraph.clinicalgenome.org/r/61YmIfkhd38","type":"GeneValidityProposition","disease":"obo:MONDO_0011444","gene":"hgnc:1943","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_c19544e0-2fb1-4d8a-b1ad-f493068f76bb-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}